Parkinson’s, T2D drug affords cardioprotection in youth with T1D | Latest news for Doctors, Nurses and Pharmacists

Bromocriptine quick release, a medication used for Parkinson’s disease and type 2 diabetes (T2D), appears to confer cardiovascular benefits such as lower blood pressure (BP) and reduced aortic stiffness in teenagers with type 1 diabetes (T1D), according to data from the BCQR-T1D study. “We know that abnormalities in the large vessels around the […]